Cross Country Healthcare gains on speculation it wasn’t subject of FTC meeting


Medical Professional Team Meeting

FatCamera/E+ via Getty Images

Cross Country Healthcare (NASDAQ:CCRN) rose 5.5% amid speculation it wasn’t the subject of a Federal Trade Commission closed-door meeting on Wednesday.

There was speculation prior to the meeting that Aya Healthcare’s planned $615 million purchase of Cross Country (NASDAQ:



Source link

The OnePlus 15’s leaked design feels like a phone without a clear identity

Jimmy Fallon Abruptly Cancels Gig Following Kimmel Firing; ‘The View’ Stars Slammed For Failure to Speak Out

Leave a Reply

Your email address will not be published. Required fields are marked *